Precision Biosciences Inc SEC filings DTIL
Precision Biosciences Inc has 606 filings in SEC EDGAR's recent list, going back to Mar 15, 2006. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (other events). The company's fiscal year ends on May 21.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 6, 2026 | Nov 5, 2026 |
| 424B5 | Prospectus supplement | Nov 6, 2026 | — |
| FWP | Free writing prospectus | Nov 5, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 24, 2026 | Aug 24, 2026 |
| S-8 | Employee stock plan registration | Aug 7, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 27, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 16, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 27, 2026 | May 27, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
May 26, 2026 | May 21, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 8, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 8, 2026 | — |
| DEF 14A | Proxy statement | Apr 8, 2026 | May 21, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2026 | May 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 17, 2026 | Mar 17, 2026 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 11, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 13, 2026 | Jan 12, 2026 |
| EFFECT | Filing | Jan 7, 2026 | — |
| CORRESP | Letter to the SEC | Jan 5, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 2, 2026 | — |
| S-3 | Shelf registration | Dec 30, 2025 | — |
| S-8 | Employee stock plan registration | Dec 30, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 12, 2025 | Nov 10, 2025 |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| FWP | Free writing prospectus | Nov 10, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 3, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2025 | Aug 26, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2025 | May 28, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2025 | May 14, 2025 |
| ARS | Annual report to shareholders | Apr 15, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 15, 2025 | — |
| DEF 14A | Proxy statement | Apr 15, 2025 | May 28, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2025 | May 28, 2025 |
| 424B5 | Prospectus supplement | Mar 26, 2025 | — |
| 10-K | Annual report | Mar 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2025 | Mar 26, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 7, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 29, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 8, 2025 | Jan 6, 2025 |
| 10-Q | Quarterly report | Nov 4, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Oct 24, 2024 | Oct 24, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 12, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2024 | Sep 3, 2024 |
| 10-Q | Quarterly report | Aug 1, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| S-8 | Employee stock plan registration | Jul 1, 2024 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 10, 2024 | Jun 4, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Other events
|
May 8, 2024 | May 8, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 4, 2024 |
| 8-K |
Current report
Agreement ended, Results of operations, Regulation FD disclosure
|
Apr 16, 2024 | Apr 11, 2024 |
| 10-K | Annual report | Mar 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2024 | Mar 27, 2024 |
| 424B5 | Prospectus supplement | Mar 4, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 1, 2024 | Mar 1, 2024 |
| FWP | Free writing prospectus | Mar 1, 2024 | — |
| 424B5 | Prospectus supplement | Feb 29, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 13, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 23, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jan 19, 2024 | Jan 18, 2024 |
| DEFA14A | Additional proxy material | Jan 12, 2024 | — |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
|
Jan 11, 2024 | Jan 7, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 22, 2023 | Dec 19, 2023 |
| DEFA14A | Additional proxy material | Dec 4, 2023 | — |
| DEF 14A | Proxy statement | Dec 4, 2023 | Jan 18, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 22, 2023 | Jan 18, 2024 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Listing notice
|
Oct 25, 2023 | Oct 24, 2023 |
| 8-K/A |
Amended current report
Material agreement, New debt
|
Oct 20, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Material agreement
|
Oct 19, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 12, 2023 | Sep 12, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 7, 2023 | Aug 31, 2023 |
| 8-K/A | Amended current report | Aug 21, 2023 | Aug 15, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Aug 16, 2023 | Aug 15, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2023 | Aug 4, 2023 |
| 10-Q | Quarterly report | Aug 4, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 6, 2023 | Jun 30, 2023 |
| EFFECT | Filing | Jun 15, 2023 | — |
| CORRESP | Letter to the SEC | Jun 13, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2023 | — |
| S-3 | Shelf registration | Jun 9, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 31, 2023 | May 31, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 9, 2023 | May 4, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Listing notice
|
Apr 28, 2023 | Apr 24, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 18, 2023 | Apr 18, 2023 |
| ARS | Annual report to shareholders | Mar 23, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Mar 23, 2023 | — |
| DEF 14A | Proxy statement | Mar 23, 2023 | May 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 10-K | Annual report | Mar 9, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 24, 2023 | Feb 22, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 10, 2022 | Nov 5, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2022 | Nov 8, 2022 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 2, 2022 | Sep 1, 2022 |
| S-8 | Employee stock plan registration | Aug 26, 2022 | — |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 18, 2022 | Jul 12, 2022 |
| 8-K |
Current report
Other events
|
Jun 22, 2022 | Jun 21, 2022 |
| 424B4 | Prospectus | Jun 22, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jun 21, 2022 | Jun 14, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jun 8, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 31, 2022 | May 31, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 12, 2022 | May 10, 2022 |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 11, 2022 | Apr 11, 2022 |
| DEFA14A | Additional proxy material | Mar 29, 2022 | — |
| DEF 14A | Proxy statement | Mar 29, 2022 | May 10, 2022 |
| 10-K | Annual report | Mar 15, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 15, 2022 | Mar 15, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 10, 2022 | Jan 4, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 21, 2021 | Dec 17, 2021 |
| 8-K |
Current report
Other events
|
Dec 13, 2021 | Dec 11, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 8, 2021 | Nov 6, 2021 |
| 8-K |
Current report
Results of operations
|
Oct 21, 2021 | Oct 21, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 27, 2021 | Sep 27, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 9, 2021 | Sep 9, 2021 |
| S-8 | Employee stock plan registration | Sep 7, 2021 | — |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2021 | Jul 2, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 7, 2021 | Jul 7, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 7, 2021 | Jun 1, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 4, 2021 | Jun 4, 2021 |
| 8-K |
Current report
Officer or director change
|
May 27, 2021 | May 26, 2021 |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 12, 2021 | May 10, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 15, 2021 | Apr 14, 2021 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, Regulation FD disclosure, Other events
|
Apr 15, 2021 | Apr 9, 2021 |
| DEF 14A | Proxy statement | Apr 12, 2021 | May 10, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 12, 2021 | Apr 8, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 6, 2021 | Apr 5, 2021 |
| 10-K | Annual report | Mar 18, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 18, 2021 | Mar 18, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 19, 2021 | Feb 19, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 25, 2021 | Jan 25, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 7, 2021 | Jan 6, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 14, 2020 | Dec 8, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 4, 2020 | Dec 4, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Nov 20, 2020 | Nov 19, 2020 |
| 10-Q | Quarterly report | Nov 10, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Material agreement
|
Oct 22, 2020 | Oct 16, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 21, 2020 | Sep 21, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 17, 2020 | Sep 17, 2020 |
| 10-Q | Quarterly report | Aug 13, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2020 | Aug 13, 2020 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Jul 6, 2020 | Jul 6, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 26, 2020 | Jun 23, 2020 |
| EFFECT | Filing | Jun 11, 2020 | — |
| CORRESP | Letter to the SEC | Jun 9, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2020 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 2, 2020 | Jun 2, 2020 |
| S-3 | Shelf registration | Jun 1, 2020 | — |
| 8-K |
Current report
Shareholder vote results
|
May 18, 2020 | May 13, 2020 |
| 10-Q | Quarterly report | May 15, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 15, 2020 | May 15, 2020 |
| 8-K |
Current report
Other events
|
Apr 6, 2020 | Apr 6, 2020 |
| DEFA14A | Additional proxy material | Mar 27, 2020 | — |
| DEF 14A | Proxy statement | Mar 27, 2020 | May 13, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 12, 2020 | Mar 12, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 11, 2020 | Mar 6, 2020 |
| 10-K | Annual report | Mar 10, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2020 | Mar 10, 2020 |
| 8-K |
Current report
Material agreement
|
Feb 6, 2020 | Feb 3, 2020 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Jan 15, 2020 | Jan 15, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 15, 2020 | Jan 15, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 13, 2019 | Nov 6, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2019 | Nov 12, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- DTIL (Nasdaq)
- Fiscal year ends
- May 21
- Incorporated in
- DE
- Headquarters
- Durham, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1357874
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.